Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Wechsler Scales
Global Health and Graduate Medical Education: A Systematic Review of the Literature.
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One. 2012; 7(9):e44743.
View in:
PubMed
subject areas
Adult
Aged
Biomarkers, Tumor
Carcinoma, Hepatocellular
Female
Hepatitis B virus
Histocompatibility Antigens Class I
Humans
Liver Neoplasms
Male
Middle Aged
Minisatellite Repeats
Neovascularization, Pathologic
Polymorphism, Single Nucleotide
Prognosis
authors with profiles
Yusuke Nakamura